Меню
Идёт набор NCT04628416

Evaluation of the PICO® Negative Pressure Dressing System on the Fibula Free Flap Donor Site's Skin Graft.

Без фазы С лечением Carcinomatous Resections Violent Trauma

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: PICO dressing, Conventional dressing.
Кому может быть актуально
Состояния в реестре: Carcinomatous Resections, Violent Trauma. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Франция
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Обзор

A fibula free flap can be used for the reconstruction of a mandible or a maxillar when the lack of bonne exceeds 3cm. This flap is made of the fibula bone, some muscle around, the fibular vascular pedicle and a skin paddle to reconstruct the gum. Once this flap has been taken and transposed on the face, the leg is closed with a split thickness skin graft to replace the skin paddle. But the healing on this site is often a problem: this is partly due to the high rate of early graft's loss due to local devascularization (3 to 55% of loss). The skin grafting is generally improved by the application of a dressing sewn and left in place during 5 to 7 days postoperative (standard method). This study will evaluate the efficiency of a portative miniature negative pressure dressing system named PICO® on the split-thickness skin graft of fibula free flap donor sites, compared to the standard method. A prospective randomized evaluation will be done, comparing the PICO® to a conventional dressing. The main aim of the study is the evaluation of the impact of this portative system on the healing of the skin grafted donor site, in terms of rate of skin take, time of healing, complications and medical costs. The patients will be seen preoperatively to decide on their inclusion in the protocol. They will be reviewed at day 10 to evaluate the engraftment and possible local complications on the donor site. They will then be reviewed at day 20 and day 30 and until complete healing. The follow up will be of 12 months maximum. A medical cost evaluation will be done comparing the costs generated by the care on the donor site in the 2 groups.

Вмешательства

  • Устройство PICO dressing
    Use of a portative miniature negative pressure dressing system named PICO® on the split-thickness skin graft of fibula free flap donor sites
  • Устройство Conventional dressing
    use of a conventional dressing (parrafin gauze) on the split-thickness skin graft of fibula free flap donor sites

Первичные конечные точки

  • The percentage of failure of skin grafting (surface on which the skin graft did not take) [Срок оценки: on Day 10 postoperative (+/- 2 days)]
Вторичные конечные точки (9)
  • Delay between the day of the operation and the complete healing of the donor site of the fibula flap (in days) [Срок оценки: Through complete healing, a maximum of 1 year]
  • Rate of other surgery due to a problem on the skin grafted area. [Срок оценки: Through complete healing, a maximum of 1 year]
  • Tendon exposure rate evaluated at day 10 (+/- 2 days) and day 20 (+/- 2 days) by the surgeon during hospitalization or in consultation if the patient is discharged. [Срок оценки: Day 10 (+/- 2 days) and day 20 (+/- 2 days)]
  • Rate of infection of the grafted site at day 10 (+/- 2 days) and day 20 (+/- 2 days), evaluated by the surgeon during hospitalization or in consultation if the patient is discharged [Срок оценки: Day 10 (+/- 2 days) and day 20 (+/- 2 days)]
  • Evolution of the quality of life at 1 month postoperative (+/- 4 days) compared to preoperative (assessed by the Short Form-12 Health Survey Version 2 (SF-12v2)) [Срок оценки: At 1 month after surgery]
  • Rate of patients for whom during of hospitalization was lengthened exclusively due to a problem with the skin graft. (Duration of hospitalization) [Срок оценки: At 12 months]
  • Evaluation of patient discomfort related to the PICO® device or to the standard dressing (noise, bulk, dressing) during the first 7 postoperative days. This discomfort is measured by an EVA of 0 to 100 measuring the discomfort experienced. [Срок оценки: day 10]
  • Treatment tolerance evaluation, measured wtih rate of adverse reaction [Срок оценки: Day 20]
  • Cost-effectiveness ratio. The medical and non-medical costs will be collect on the case report form [Срок оценки: At 12 months]

Критерии участия

Критерии включения

  • Patients over 18 years old
  • Any patient requiring a fibula free flap with skin paddle
  • Theoretical need of a skin graft for the closure of the donor site (evaluated by the surgeon in charge of the patient at the time of inclusion) and performed at the same time as the fibula flap
  • Signature of informed consent.

Критерии исключения

  • Contraindication to making a fibula free flap:
  • anesthetic contraindication,
  • atheroma in the leg arteries obstructing more than 60% of the arterial lumen (objectified by CT angiography of lower limbs)
  • Contraindication to the setting up of a negative pressure therapy:
  • allergy to one of the PICO® components
  • infection in the donor area
  • cutaneous lesions of the lower limb preventing the placement of an occlusive dressing or making it impossible to seal the device
  • No affiliation to a social security scheme.
  • Minor or major patients who are protected or unable to give their consent (according to article L1121-8 of the Public Health Code (PHC))
  • Pregnant or lactating women (according to article L1121-5 of the PHC)
  • Vulnerable people (according to article L1121-6 of the PHC)

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Лечение

Центры проведения

Франция · 1 центр
  • Marie DE BOUTRAY — Montpellier

Идентификаторы

NCT: NCT04628416 · RECHMPL20_0047 · 2020-A00425-34

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗